Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Endocrinology|May 24, 2023
Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumorsMaria J Klomp, Julie Refardt, Peter M van Koetsveld, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 10, 2003
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cellsVirgil A S H Dalm, P Martin van Hagen, Peter M van Koetsveld, et al.
European Journal of Endocrinology|October 16, 2012
Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndromeJohannes Hofland, Wouter W de Herder, Lieke Derks, et al.
Pharmaceutics|January 21, 2022
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In VivoMaria J Klomp, Leo J Hofland, Lilian van den Brink, et al.
Endocrine-Related Cancer|March 20, 2013
Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotanePeter M van Koetsveld, Giovanni Vitale, Richard A Feelders, et al.
European Journal of Endocrinology|April 9, 2005
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5Leo J Hofland, Joost van der Hoek, Richard Feelders, et al.
Biotechnology Advances|August 30, 2011
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cellsGiovanni Vitale, Silvia Zappavigna, Monica Marra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitroLeo J Hofland, Joost van der Hoek, Peter M van Koetsveld, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary AdenomasFederico Gatto, Richard A Feelders, Sanne E Franck, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 12, 2002
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytesDiego Ferone, Rosario Pivonello, P Martin Van Hagen, et al.
Pageof 7